Role of proteomic technologies in understanding risk of arterial thrombosis

References

• Nagata Y, Usuda K, Uchiyama A et al. Characteristics of the pathological images of coronary artery thrombi according to the infarct-related coronary artery in acute myocardial infarction. Circ. J.68(4), 308–314 (2004).
   PubMed Web of Science ®Google Scholar
• Aebersold R. A mass spectrometric journey into protein and proteome research. J. Am. Soc. Mass Spectrom.14(7), 685–695 (2003).
   PubMed Web of Science ®Google Scholar
• Matt P, Fu Z, Fu Q, Van Eyk JE. Biomarker discovery: proteome fractionation and separation in biological samples. Physiol. Genomics33(1), 12–17 (2008).
   PubMed Web of Science ®Google Scholar
• Kislinger T, Emili A. Multidimensional protein identification technology: current status and future prospects. Expert Rev. Proteomics2(1), 27–39 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang G, Neubert TA. Use of stable isotope labeling by amino acids in cell culture (SILAC) for phosphotyrosine protein identification and quantitation. Methods Mol. Biol.527, 79–92, xi (2009).
   PubMedGoogle Scholar
• Lilley KS, Friedman DB. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev. Proteomics1(4), 401–409 (2004).
   PubMed Web of Science ®Google Scholar
• Drake TA, Ping P. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Proteomics approaches to the systems biology of cardiovascular diseases. J. Lipid Res.48(1), 1–8 (2007).
   PubMed Web of Science ®Google Scholar
• Meilhac O, Delbosc S, Michel JB. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry. Methods Mol. Biol.357, 331–341 (2007).
   PubMedGoogle Scholar
• Fournier I, Wisztorski M, Salzet M. Tissue imaging using MALDI-MS: a new frontier of histopathology proteomics. Expert Rev. Proteomics5(3), 413–424 (2008).
   PubMed Web of Science ®Google Scholar
• Franck J, Arafah K, Elayed M et al. MALDI imaging: State of the art technology in clinical proteomics. Mol. Cell Proteomics DOI: 10.1007/s00418-008-0469-0469 (2009) (Epub ahead of print).
   Google Scholar
• Duran MC, Mas S, Martin-Ventura JL et al. Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics3(6), 973–978 (2003).
   PubMed Web of Science ®Google Scholar
• Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation111(25), 3481–3488 (2005).
   PubMed Web of Science ®Google Scholar
• Karabina SA, Brocheriou I, Le Naour G et al. Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function. FASEB J.20(14), 2547–2549 (2006).
   PubMed Web of Science ®Google Scholar
• Chen CY, Lee CM, Hsu HC, Yang CY, Chow LP, Lee YT. Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell. Life Sci.80(26), 2469–2480 (2007).
   PubMed Web of Science ®Google Scholar
• Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest.115(10), 2656–2664 (2005).
   PubMed Web of Science ®Google Scholar
• Wang XL, Fu A, Raghavakaimal S, Lee HC. Proteomic analysis of vascular endothelial cells in response to laminar shear stress. Proteomics7(4), 588–596 (2007).
   PubMed Web of Science ®Google Scholar
• Wu J, Liu W, Sousa E et al. Proteomic identification of endothelial proteins isolated in situ from atherosclerotic aorta via systemic perfusion. J. Proteome Res.6(12), 4728–4736 (2007).
   PubMed Web of Science ®Google Scholar
• Aird WC. Spatial and temporal dynamics of the endothelium. J. Thromb. Haemost.3(7), 1392–1406 (2005).
   PubMed Web of Science ®Google Scholar
• Banfi C, Brioschi M, Wait R et al. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics5(17), 4443–4455 (2005).
   PubMed Web of Science ®Google Scholar
• van Mourik JA, Romani dW, Voorberg J. Biogenesis and exocytosis of Weibel–Palade bodies. Histochem. Cell. Biol.117(2), 113–122 (2002).
   PubMed Web of Science ®Google Scholar
• Carter AM. Inflammation, thrombosis and acute coronary syndromes. Diab. Vasc. Dis. Res.2(3), 113–121 (2005).
   PubMedGoogle Scholar
• Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation111(25), 3481–3488 (2005).
   PubMed Web of Science ®Google Scholar
• Jin M, Opalek JM, Marsh CB, Wu HM. Proteome comparison of alveolar macrophages with monocytes reveals distinct protein characteristics. Am. J. Respir. Cell Mol. Biol.31(3), 322–329 (2004).
   PubMed Web of Science ®Google Scholar
• Barderas MG, Tunon J, Darde VM et al. Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome. Proteomics9(7), 1982–1993 (2009).
   PubMed Web of Science ®Google Scholar
• Barderas MG, Darde VM, Duran MC, Egido J, Vivanco F. Characterization of circulating human monocytes by proteomic analysis. Methods Mol. Biol.357, 319–328 (2007).
   PubMedGoogle Scholar
• Barderas MG, Tunon J, Darde VM et al. Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. J. Proteome Res.6(2), 876–886 (2007).
   PubMed Web of Science ®Google Scholar
• Vergara D, Chiriaco F, Acierno R, Maffia M. Proteomic map of peripheral blood mononuclear cells. Proteomics8(10), 2045–2051 (2008).
   PubMed Web of Science ®Google Scholar
• Jin M, Diaz PT, Bourgeois T et al. 2D gel proteome reference map of blood monocytes. Proteome Sci.4, 16 (2006).
   PubMed Web of Science ®Google Scholar
• Dotzlaw H, Schulz M, Eggert M, Neeck G. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim. Biophys. Acta1696(1), 121–129 (2004).
   PubMed Web of Science ®Google Scholar
• Fuchs D, Piller R, Linseisen J, Daniel H, Wenzel U. The human peripheral blood mononuclear cell proteome responds to a dietary flaxseed-intervention and proteins identified suggest a protective effect in atherosclerosis. Proteomics7(18), 3278–3288 (2007).
   PubMed Web of Science ®Google Scholar
• Skopeliti M, Kratzer U, Altenberend F et al. Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation. Proteomics.7(11), 1814–1824 (2007).
   PubMed Web of Science ®Google Scholar
• Kang JH, Ryu HS, Kim HT et al. Proteomic analysis of human macrophages exposed to hypochlorite-oxidized low-density lipoprotein. Biochim. Biophys. Acta1794(3), 446–458 (2009).
   PubMed Web of Science ®Google Scholar
• Dupont A, Chwastyniak M, Beseme O et al. Application of saturation dye 2D-DIGE proteomics to characterize proteins modulated by oxidized low density lipoprotein treatment of human macrophages. J. Proteome Res7(8), 3572–3582 (2008).
   PubMed Web of Science ®Google Scholar
• Rosengren AT, Nyman TA, Lahesmaa R. Proteome profiling of interleukin-12 treated human T helper cells. Proteomics5(12), 3137–3141 (2005).
   PubMed Web of Science ®Google Scholar
• Nyman TA, Rosengren A, Syyrakki S, Pellinen TP, Rautajoki K, Lahesmaa R. A proteome database of human primary T helper cells. Electrophoresis22(20), 4375–4382 (2001).
   PubMed Web of Science ®Google Scholar
• Rautajoki K, Nyman TA, Lahesmaa R. Proteome characterization of human T helper 1 and 2 cells. Proteomics4(1), 84–92 (2004).
   PubMed Web of Science ®Google Scholar
• Loyet KM, Ouyang W, Eaton DL, Stults JT. Proteomic profiling of surface proteins on Th1 and Th2 cells. J. Proteome Res.4(2), 400–409 (2005).
   PubMed Web of Science ®Google Scholar
• McGregor E, Kempster L, Wait R et al. Identification and mapping of human saphenous vein medial smooth muscle proteins by two-dimensional polyacrylamide gel electrophoresis. Proteomics1(11), 1405–1414 (2001).
   PubMed Web of Science ®Google Scholar
• Dupont A, Corseaux D, Dekeyzer O et al. The proteome and secretome of human arterial smooth muscle cells. Proteomics5(2), 585–596 (2005).
   PubMed Web of Science ®Google Scholar
• Boccardi C, Cecchettini A, Caselli A et al. A proteomic approach to the investigation of early events involved in vascular smooth muscle cell activation. Cell Tissue Res.328(1), 185–195 (2007).
   PubMed Web of Science ®Google Scholar
• Van Craeyveld E, Lievens J, Jacobs F, Feng Y, Snoeys J, De Geest B. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions. Gene Ther.16(6), 757–765. (2009).
   PubMed Web of Science ®Google Scholar
• Trivedi V, Boire A, Tchernychev B et al. Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell137(2), 332–343 (2009).
   PubMed Web of Science ®Google Scholar
• Diebold I, Kraicun D, Bonello S, Gorlach A. The ‘PAI-1 paradox’ in vascular remodeling. Thromb. Haemost.100(6), 984–991 (2008).
   PubMed Web of Science ®Google Scholar
• Cosemans JM, Iserbyt BF, Deckmyn H, Heemskerk JW. Multiple ways to switch platelet integrins on and off. J. Thromb. Haemost.6(8), 1253–1261 (2008).
   PubMed Web of Science ®Google Scholar
• Rivera J, Lozano ML, Navarro-Nunez L, Vicente V. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica94(5), 700–711 (2009).
   PubMed Web of Science ®Google Scholar
• Garcia A, Watson SP, Dwek RA, Zitzmann N. Applying proteomics technology to platelet research. Mass Spectrom. Rev.24(6), 918–930 (2005).
   PubMed Web of Science ®Google Scholar
• Garcia A, Prabhakar S, Hughan S et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood103(6), 2088–2095 (2004).
   PubMed Web of Science ®Google Scholar
• Garcia A, Senis YA, Antrobus R et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics6(19), 5332–5343 (2006).
   PubMed Web of Science ®Google Scholar
• Maguire PB, Wynne KJ, Harney DF, O’Donoghue NM, Stephens G, Fitzgerald DJ. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics2(6), 642–648 (2002).
   PubMed Web of Science ®Google Scholar
• Guerrier L, Claverol S, Fortis F et al. Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries. J. Proteome Res6(11), 4290–4303 (2007).
   PubMed Web of Science ®Google Scholar
• Zahedi RP, Lewandrowski U, Wiesner J et al. Phosphoproteome of resting human platelets. J. Proteome Res7(2), 526–534 (2008).
   PubMed Web of Science ®Google Scholar
• Gevaert K, Goethals M, Martens L et al. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol.21(5), 566–569 (2003).
   PubMed Web of Science ®Google Scholar
• Martens L, Van Damme P, Van Damme J et al. The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics5(12), 3193–3204 (2005).
   PubMed Web of Science ®Google Scholar
• Blair P, Flaumenhaft R. Platelet α-granules: Basic biology and clinical correlates. Blood Rev.23(4), 177–189 (2009).
   PubMed Web of Science ®Google Scholar
• Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc. Natl Acad. Sci. USA103(4), 903–908 (2006).
   PubMed Web of Science ®Google Scholar
• Coppinger JA, Cagney G, Toomey S et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood103(6), 2096–2104 (2004).
   PubMed Web of Science ®Google Scholar
• Maynard DM, Heijnen HF, Horne MK, White JG, Gahl WA. Proteomic analysis of platelet α-granules using mass spectrometry. J. Thromb. Haemost.5(9), 1945–1955 (2007).
   PubMed Web of Science ®Google Scholar
• Italiano JE, Jr., Richardson JL, Patel-Hett S et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released. Blood111(3), 1227–1233 (2008).
   PubMed Web of Science ®Google Scholar
• Sehgal S, Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J. Thromb. Haemost.5(10), 2009–2016 (2007).
   PubMed Web of Science ®Google Scholar
• Hernandez-Ruiz L, Valverde F, Jimenez-Nunez MD et al. Organellar proteomics of human platelet dense granules reveals that 14–13–3ζ is a granule protein related to atherosclerosis. J. Proteome Res.6(11), 4449–4457 (2007).
   PubMed Web of Science ®Google Scholar
• Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF. The platelet microparticle proteome. J. Proteome Res4(5), 1516–1521 (2005).
   PubMed Web of Science ®Google Scholar
• Moebius J, Zahedi RP, Lewandrowski U, Berger C, Walter U, Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol. Cell Proteomics4(11), 1754–1761 (2005).
   PubMed Web of Science ®Google Scholar
• Hartinger J, Stenius K, Hogemann D, Jahn R. 16-BAC/SDS-PAGE: a two-dimensional gel electrophoresis system suitable for the separation of integral membrane proteins. Anal. Biochem.240(1), 126–133 (1996).
   PubMed Web of Science ®Google Scholar
• Senis YA, Tomlinson MG, Garcia A et al. A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein. Mol. Cell. Proteomics6(3), 548–564 (2007).
   PubMed Web of Science ®Google Scholar
• Lewandrowski U, Wortelkamp S, Lohrig K et al. Platelet membrane proteomics: a novel repository for functional research. Blood114(1), E10–19 (2009).
   PubMed Web of Science ®Google Scholar
• Standeven KF, Ariens RA, Grant PJ. The molecular physiology and pathology of fibrin structure/function. Blood Rev.19(5), 275–288 (2005).
   PubMed Web of Science ®Google Scholar
• Fatah K, Hamsten A, Blomback B, Blomback M. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb. Haemost.68(2), 130–135 (1992).
   PubMed Web of Science ®Google Scholar
• Fatah K, Silveira A, Tornvall P, Karpe F, Blomback M, Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb. Haemost.76(4), 535–540 (1996).
   PubMed Web of Science ®Google Scholar
• Carter AM, Cymbalista CM, Spector TD, Grant PJ. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler. Thromb. Vasc. Biol.27(12), 2783–2789 (2007).
   PubMed Web of Science ®Google Scholar
• Bhasin N, Ariens RA, West RM, Parry DJ, Grant PJ, Scott DJ. Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication. J. Vasc. Surg.48(6), 1497–1503, 1503 (2008).
   PubMed Web of Science ®Google Scholar
• Carr ME. Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen. Thromb. Haemost.59(3), 535–539 (1988).
   PubMedGoogle Scholar
• Saha S, Harrison SH, Shen C et al. HIP2: an online database of human plasma proteins from healthy individuals. BMC Med. Genomics1, 12 (2008).
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics1(11), 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Omenn GS, States DJ, Adamski M et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics5(13), 3226–3245 (2005).
   PubMed Web of Science ®Google Scholar
• Guerrier L, Thulasiraman V, Castagna A et al. Reducing protein concentration range of biological samples using solid-phase ligand libraries. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.833(1), 33–40 (2006).
   PubMed Web of Science ®Google Scholar
• Restuccia U, Boschetti E, Fasoli E et al. pI-based fractionation of serum proteomes versus anion exchange after enhancement of low-abundance proteins by means of peptide libraries. J. Proteomics72(6), 1061–1070 (2009).
   PubMed Web of Science ®Google Scholar
• Pernemalm M, Lewensohn R, Lehtiö J. Affinity prefractionation for MS-based plasma proteomics. Proteomics9(6), 1420–1427 (2009).
   PubMed Web of Science ®Google Scholar
• Misek DE, Kuick R, Wang H et al. A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics5(13), 3343–3352 (2005).
   PubMed Web of Science ®Google Scholar
• Tammen H, Schulte I, Hess R et al. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics5(13), 3414–3422 (2005).
   PubMed Web of Science ®Google Scholar
• Marshall J, Kupchak P, Zhu W et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res.2(4), 361–372 (2003).
   PubMed Web of Science ®Google Scholar
• Donahue MP, Rose K, Hochstrasser D et al. Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am. Heart J.152(3), 478–485 (2006).
   PubMed Web of Science ®Google Scholar
• Hong M, Zhang X, Hu Y et al. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS. Thromb. Res.123(3), 556–564 (2009).
   PubMed Web of Science ®Google Scholar
• Howes J-M, Keen JN, Findlay JB, Carter AM. The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease. Diab. Vasc. Dis. Res.5(3), 205–212 (2008).
   PubMed Web of Science ®Google Scholar
• Rijken DC, Dirkx SP, Luider TM, Leebeek FW. Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clot. Biochem. Biophys. Res. Commun.350(1), 191–194 (2006).
   PubMed Web of Science ®Google Scholar
• Howes J-M, Kenn JN, Findlay JBC, Grant PJ, Carter AM. Deciphering the plasma clot proteome. Mol. Cell. Proteomics3, S218 (2004).
   Google Scholar
• Orru S, Caputo I, D’Amato A, Ruoppolo M, Esposito C. Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease. J. Biol. Chem.278(34), 31766–31773 (2003).
   PubMed Web of Science ®Google Scholar
• Ruoppolo M, Orru S, D’Amato A et al. Analysis of transglutaminase protein substrates by functional proteomics. Protein Sci.12(6), 1290–1297 (2003).
   PubMed Web of Science ®Google Scholar